Clinical trial
The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
NCT04593563 is registered in ClinicalTrials.gov with Maryland Oncology Hematology, PA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
- Lead sponsor
- Maryland Oncology Hematology, PA
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- September 1, 2020
- Completion date
- October 31, 2023
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.